THC 10-Q Quarterly Report March 31, 2018 | Alphaminr
TENET HEALTHCARE CORP

THC 10-Q Quarter ended March 31, 2018

TENET HEALTHCARE CORP
10-Ks and 10-Qs
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on April 12, 2024
DEF 14A
Filed on April 14, 2023
DEF 14A
Filed on March 25, 2022
DEF 14A
Filed on March 26, 2021
DEF 14A
Filed on April 17, 2020
DEF 14A
Filed on March 22, 2019
DEF 14A
Filed on March 30, 2018
DEF 14A
Filed on March 24, 2017
DEF 14A
Filed on March 31, 2016
DEF 14A
Filed on March 27, 2015
DEF 14A
Filed on March 28, 2014
DEF 14A
Filed on March 22, 2013
DEF 14A
Filed on March 30, 2012
DEF 14A
Filed on Sept. 23, 2011
DEF 14A
Filed on March 25, 2010
TABLE OF CONTENTS
Part I. Financial InformationItem 1. Financial StatementsNote 1. Basis Of PresentationNote 2. Accounts ReceivableNote 3. Contract BalancesNote 4. Assets and Liabilities Held For SaleNote 5. Impairment and Restructuring Charges, and Acquisition-related CostsNote 6. Long-term Debt and Lease ObligationsNote 7. GuaranteesNote 8. Employee Benefit PlansNote 9. EquityNote 10. Net Operating RevenuesNote 11. Property and Professional and General Liability InsuranceNote 12. Claims and LawsuitsNote 13. Redeemable Noncontrolling Interests in Equity Of Consolidated SubsidiariesNote 14. Income TaxesNote 15. Earnings (loss) Per Common ShareNote 16. Fair Value MeasurementsNote 17. AcquisitionsNote 18. Segment InformationNote 19. Recent Accounting StandardsNote 20. Subsequent EventsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 5. Other InformationItem 6. Exhibits

Exhibits

(a) Certificate of Withdrawal of Certificate of Designation of Series R Preferred Stock, par value $0.15 per share, dated March 5, 2018 (Incorporated by reference to Exhibit3.1 to Registrants Current Report on Form 8-K filed March5,2018) (b) Amended and Restated Bylaws of the Registrant, as amended and restated effective March23,2018 (Incorporated by reference to Exhibit3.2 to Registrants Current Report on Form8-K filed March26,2018) (a) Amendment No. 1, dated March 5, 2018, to Rights Agreement, dated as of August 31, 2017, between the Registrant and ComputershareTrust Company, N.A., as Rights Agent (Incorporated by reference to Exhibit4.1 to Registrants Current Report on Form 8-K filed March 5, 2018) (a) Support Agreement, dated March 23, 2018, between the Registrant and Glenview Capital Management,LLC, Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., GlenviewInstitutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund (Incorporated by reference to Exhibit10.1 to Registrants CurrentReport on Form8-K filed March26,2018) (b) Employment Agreement, dated March24,2018, between the Registrant and RonaldA.Rittenmeyer (Incorporated by reference to Exhibit10.2 to Registrants CurrentReport on Form8-K filed March26,2018)* (c) Terms and Conditions of Restricted Stock Unit Award granted to RonaldA.Rittenmeyer under the TenetHealthcare 2008Stock Incentive Plan* (a) Certification of Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer (b) Certification of Daniel J. Cancelmi, Chief Financial Officer (32) Section1350 Certification of Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer, and DanielJ.Cancelmi, ChiefFinancial Officer